SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001128732-20-000003
Filing Date
2020-07-10
Accepted
2020-07-10 13:26:24
Documents
1
Period of Report
2019-10-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7538
  Complete submission text file 0001128732-20-000003.txt   9166
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4
Business Address
Slilaty Steve N. (Reporting) CIK: 0001474684 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52898 | Film No.: 201022698